German biotech company to partner with Rwanda

- Advertisement - (adsbygoogle = window.adsbygoogle || []).push({});

BERLIN (CU)_During the past week, COVID-19 vaccinations in the Africa tripled to 13 million doses as donations of vaccines increased from developed nations. However, this still remains a drop in an ocean in a region home to 1.3 billion people, of which only 2.4 per cent has been vaccinated so far. Therefore, with the aim of setting up a sustainable Coronavirus vaccine manufacturing programme in the African continent, the government officials of Rwanda and Senegal met with the top executives of German biotechnology company BioNTech. The President of the European Commission Ursula von der Leyen also participated in the meeting that was held in Berlin on Friday (27 August).  

BioNTech is well known for its recent collaboration with…

Hot this week

UK Housing Market Sees Decade-High Supply as Prices Remain Under Pressure

The housing market in the United Kingdom is experiencing...

Why Big Investors in India Are Moving from Homes to Offices, Warehouses and Data Centres

The US$85.5 billion figure quantifies India's property market and...

What Happens When Microplastics Meet Water? Scientists Find a Potential Health Risk

We often hear that plastic is chemically inert. That...

A Mass Was Being Livestreamed in Ecuador When a Giant Crucifix Fell on the Priest

A Catholic priest in Ecuador has died after a...
- Advertisement - (adsbygoogle = window.adsbygoogle || []).push({});

Related Articles

- Advertisement -sitaramatravels.comsitaramatravels.com

Popular Categories